C-reactive protein in patients with acute heart failure and preserved ejection fraction. Villar S, Mollar A, Lorenzo M, Nunez G, de la Espriella R, Nunez J. Revista Espanola de Cardiologia (English ed.). 2023 Nov 22:S1885-5857(23)00309-2. doi:
10.1016/j.rec.2023.11.002. PMID:
38000626
CA125 for fluid overload monitoring a new life for an old tool. Bayes-Genis A, de la Espriella R, Núñez J. Journal of the American College of Cardiology. 2023 Jul 11;82(2):158-160. doi: 10.1016/j.jacc.2023.05.016. PMID: 37407114
Cardiac magnetic resonance outperforms echocardiography to predict subsequent implantable cardioverter defibrillator therapies in ST-segment elevation myocardial infarction patients. Marcos-Garces V, Perez N, Gavara J, Lopez-Lereu M, Monmeneu J, Rios-Navarro C, de Dios E, Merenciano-Gonzalez H, Gabaldon-Perez A, Ferrero-de-Loma-Osorio A, Martinez-Brotons A, Bondanza L, Sanchez-Gomez J, Albiach C, Nunez J, Bayes-Genis A, Chorro F, Ruiz-Granell R, Bodi V. Frontiers in Cardiovascular Medicine. 2023 Feb 3;10:991307. doi: 10.3389/fcvm.2023.991307. PMID: 36818338
Case report: Alternative approach for management of refractory volume overload in heart failure: usefulness of venous leg compression. Macián C, Pocull D, Dominguez F, López-Azor J, Garcia-Pavia P, Nuñez J, Marcos M. Frontiers in Cardiovascular Medicine. 2023 Sep 29:10:1230980. doi: 10.3389/fcvm.2023.1230980. PMID: 37840957
Chronotropic index and long-term outcomes in heart failure with preserved ejection fraction. Palau P, Dominguez E, Seller J, Sastre C, Sanchis J, Lopez L, Bodi V, Llacer P, Minana G, Espriella R, Bayes-Genis A, Nunez J. Revista Espanola de Cardiologia (English ed.). 2023 Jul;76(7):511-518. doi: 10.1016/j.rec.2022.08.003. PMID: 36038124
Clinical predictors and prognosis of Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) without ST-Segment elevation in older adults. Gabaldon Perez A, Bonanad C, Garcia Blas S, Marcos Garces V, Gonzalez D’Gregorio J, Fernandez Cisnal A, Valero E, Minana G, Merenciano Gonzalez H, Mollar A, Bodi V, Nunez J, Sanchis J. Journal of Clinical Medicine. 2023 Feb 2;12(3):1181. doi: 10.3390/jcm12031181. PMID: 36769828
Consensus document on palliative care in cardiorenal patients. Bonanad C, Buades J, Leiva J, de la Espriella R, Marcos M, Núñez J, García-Llana H, Facila L, Sánchez R, Rodríguez-Osorio L, Alonso-Babarro A, Quiroga B, Berroteran D, Rodríguez C, Maidana D, Díez J. Frontiers in Cardiovascular Medicine. 2023 Dec 19:10:1225823. doi: 10.3389/fcvm.2023.1225823. PMID: 38179502
Correction to: Diagnosis of heart failure with preserved ejection fraction: a systematic narrative review of the evidence. Formiga F, Nuñez J, Moraga MJC, Marcos MC, Egocheaga MI, García-Prieto CF, Trueba-Sáiz A, Gilarranz AM, Rodriguez JMF. Heart Failure Reviews. 2023 Nov 13. doi: 10.1007/s10741-023-10365-8. PMID: 37953396
Corrigendum to Hyperkalemia in acute heart failure: short term outcomes from the EAHFE registry [American Journal of Emergency Medicine, 70C (2023) 1-9]. Rafique Z, Fortuny MJ, Kuo D, Szarpak L, Llauger L, Espinosa B, Gil V, Jacob J, Alquézar-Arbé A, Andueza JA, Garrido JM, Aguirre A, Fuentes M, Alonso H, Lucas-Imbernón FJ, Bibiano C, Burillo-Putze G, Núñez J, Mullens W, Lopez-Ayala P, Mueller C, Llorens P, Peacock F, Miró Ò. American Journal of Emergency Medicine. 2023 Sep;71:251. doi: 10.1016/j.ajem.2023.05.022. PMID: 37268493
Current role of SLGT2 inhibitors in the management of the whole spectrum of heart failure: focus on dapagliflozin. Escobar C, Pascual-Figal D, Manzano L, Nuñez J, Camafort M. Journal of Clinical Medicine. 2023 Oct 27;12(21):6798. doi: 10.3390/jcm12216798. PMID: 37959263
Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction. Amiguet M, Palau P, Dominguez E, Seller J, Pinilla J, de la Espriella R, Minana G, Valle A, Sanchis J, Gorriz J, Bayes-Genis A, Nunez J. Scientific Reports. 2023 Jun 30;13(1):10591. doi: 10.1038/s41598-023-37491-5. PMID: 37391470
Derivation and external validation of machine-learning- models for risk stratification in chest pain with normal troponin. Fernandez-Cisnal A, Lopez-Ayala P, Valero E, Koechlin L, Catarrala A, Boeddinghaus J, Noceda J, Nestelberger T, Miro Andreu O, Nunez J, Mueller C, Sanchis J. European Heart Journal. Acute Cardiovascular Care. 2023 Nov 16;12(11):743-752. doi: 10.1093/ehjacc/zuad089. PMID: 37531633
Diagnosis of heart failure with preserved ejection fraction: a systematic narrative review of the evidence. Formiga F, Nuñez J, Moraga M, Marcos M, Egocheaga M, García-Prieto C, Trueba-Sáiz A, Gilarranz A, Rodriguez J. Heart Failure Reviews. 2023 Oct 20. doi: 10.1007/s10741-023-10360-z. PMID: 37861854
Early glomerular filtration rate decline is associated with hemoglobin rise following dapagliflozin initiation in heart failure with reduced ejection fraction. Minana G, de la Espriella R, Palau P, Amiguet M, Seller J, Garcia Pinilla J, Nunez E, Gorriz J, Valle A, Sanchis J, Genis A, Nunez J. Revista Espanola De Cardiologia (english Ed.). 2023 Oct;76(10):783-792. doi: 10.1016/j.rec.2023.03.007. PMID: 36958534
Early glomerular filtration rates changes and risk of mortality in acute heart failure. The modifying role of admission renal function and decongestion. Lorenzo M, Nunez G, Fuertes-Kenneally L, de la Espriella R, Villar S, Miro O, Llorens P, Santas E, Minana G, Bodi V, Sanchis J, Carratala A, Bayes-Genis A, Nunez J. European Journal of Internal Medicine. 2023 Sep;115:96-103. doi: 10.1016/j.ejim.2023.05.037. PMID: 37316355
Effect of paced heart rate on quality of life and natriuretic peptides for stage B or C HFpEF: a secondary analysis of the myPACE Trial. De la Espriella R, Wahlberg K, Infeld M, Palau P, Nunez E, Sanchis J, Meyer M, Nunez J. European Journal of Heart Failure. 2023 Dec 20. doi: 10.1002/ejhf.3107. PMID: 38124404
Effect of routine invasive vs conservative strategy in older adults with frailty and non-st-segment elevation acute myocardial infarction: a randomized clinical trial. Sanchis J, Bueno H, Minana G, Guerrero C, Marti D, Martinez-Selles M, Dominguez-Perez L, Diez-Villanueva P, Barrabes J, Marin F, Villa A, Sanmartin M, Llibre C, Sionis A, Carol A, Garcia-Blas S, Calvo E, Morales Gallardo M, Elizaga J, Gomez-Blazquez I, Alfonso F, Garcia Del Blanco B, Nunez J, Formiga F, Ariza-Sole A. JAMA Internal Medicine. 2023 May 1;183(5):407-415. doi: 10.1001/jamainternmed.2023.0047. PMID: 36877502
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study. Karasik A, Lanzinger S, Chia-Hui Tan E, Yabe D, Kim DJ, Sheu WHH, Melzer-Cohen C, Holl RW, Ha KH, Khunti K, Zaccardi F, Subramanian A, Nirantharakumar K, Nystrom T, Niskanen L, Linnemann Jensen M, Hoti F, Klement R, Deruaz-Luyet A, Kyaw MH, Koeneman L, Vistisen D, Carstensen B, Halvorsen S, Langslet G, Fazeli Farsani S, Patorno E, Nunez J. Diabetes & Metabolism. 2023 Jan 3;49(2):101418. doi: 10.1016/j.diabet.2022.101418. PMID: 36608816
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia. Vistisen D, Carstensen B, Elisabetta P, Lanzinger S, Tan E, Yabe D, Kim D, Sheu W, Melzer-Cohen C, Holl R, Núñez J, Ha K, Halvorsen S, Langslet G, Karasik A, Nyström T, Niskanen L, Guleria S, Klement R, Carrasco M, Foersch J, Shay C, Koeneman L, Hoti F, Farsani S, Khunti K, Zaccardi F, Subramanian A, Nirantharakumar K. Cardiovascular Diabetology. 2023 Aug 31;22(1):233. doi: 10.1186/s12933-023-01963-9. PMID: 37653496
Evaluation of functional warm ischemia time during controlled donation after circulatory determination of death using normothermic regional perfusion (ECMO-TT): a prospective multicenter cohort study. Martinez-Castro S, Navarro R, Garcia-Perez M, Segura J, Carbonell J, Hornero F, Guijarro J, Zaplana M, Bruno M, Tur A, Martinez-Leon J, Zaragoza R, Nunez J, Dominguez-Gil B, Badenes R. Artificial Organs. 2023 Aug;47(8):1371-1385. doi: 10.1111/aor.14539. PMID: 37042612
Evolocumab has no effects on HFrEF injury biomarkers: the EVO-HF trial. Bayes-Genis A, Lupon J, Revuelta-Lopez E, Llibre C, Gastelurrutia P, Domingo M, Cediel G, Codina P, Santiago-Vacas E, Rangel-Sousa D, Fernandez-Cisnal A, Minana G, Mollar A, Nunez J. European Journal of Heart failure. 2023 Aug;25(8):1439-1443. doi: 10.1002/ejhf.2932. PMID: 37323111
Exercise-induced hypoalgesia with end-stage knee osteoarthritis during different blood flow restriction levels: sham-controlled crossover study. Ogrezeanu D, Lopez-Bueno L, Sanchis-Sanchez E, Suso-Marti L, Lopez-Bueno R, Nunez-Cortes R, Cruz-Montecinos C, Perez-Alenda S, Casana J, Gargallo P, Calatayud J. PM & R. 2023 Oct 5. doi: 10.1002/pmrj.13076. PMID: 37796567
Frailty and outcomes in heart failure patients from high-, middle-, and low-income countries. Leong D, Joseph P, Mcmurray J, Rouleau J, Maggioni A, Lanas F, Sharma S, Núñez J, Mohan B, Celik A, Abdullakutty J, Ogah O, Mielniczuk L, Balasubramanian K, Mccready T, Grinvalds A, Yusuf S. European Heart Journal. 2023 Nov 7;44(42):4435-4444. doi: 10.1093/eurheartj/ehad595. PMID: 37639487
Galectin-3, acute kidney injury and myocardial damage in patients with acute heart failure. Horiuchi Y, Wettersten N, VAN Veldhuisen D, Mueller C, Filippatos G, Nowak R, Hogan C, Kontos M, Cannon C, Mueller G, Birkhahn R, Taub P, Vilke G, McDonald K, Mahon N, Nunez J, Briguori C, Passino C, Duff S, Maisel A, Murray P. Journal of Cardiac Failure. 2022 Nov 1;S1071-9164(22)01171-X. doi: 10.1016/j.cardfail.2022.09.017. PMID: 36332898
Geographic differences in patients with acute myocardial infarction in the PARADISE-MI Trial. Butt J, Claggett B, Miao Z, Jering K, Sim D, van der Meer P, Ntsekhe M, Amir O, Cho M, Carrillo-Calvillo J, Nunez J, Cadena A, Kerkar P, Maggioni A, Steg P, Granger C, Mann D, Merkely B, Lewis E, Solomon S, Zhou Y, Kober L, Braunwald E, McMurray J, Pfeffer M. European Journal of Heart Failure. 2023 Aug;25(8):1228-1242. doi: 10.1002/ejhf.2851. PMID: 37042062
Hospital development of heart failure follow-up units and short-term prognosis after acute decompensation in Spain. Lopez Diez MP, Alquezar Arbe A, Jacob J, Llorens P, Llauger L, Herrero P, Gil V, Nunez J, Martin Sanchez FJ, Miro O. International Journal of Cardiology. 2023 May 1;378:64-70. doi: 10.1016/j.ijcard.2023.02.031. PMID: 36804513
Hyperkalemia in acute heart failure: short term outcomes from the EAHFE registry. Rafique Z, Fortuny M, Kuo D, Szarpak L, Llauger L, Espinosa B, Gil V, Jacob J, Alquezar-Arbe A, Andueza J, Garrido J, Aguirre A, Fuentes M, Alonso H, Lucas-Imbernon F, Bibiano C, Burillo-Putze G, Nunez J, Mullens W, Lopez-Ayala P, Mueller C, Llorens P, Peacock F, Miro O. The American Journal of Emergency Medicine. 2023 May 9;70:1-9. doi: 10.1016/j.ajem.2023.05.005. PMID: 37186977
Identifying the patient with heart failure to be treated with vericiguat. Escobar Cervantes C, Esteban Fernandez A, Recio Mayoral A, Mirabet S, Gonzalez Costello J, Rubio Gracia J, Nunez J, Gonzalez Franco A, Bonilla Palomas J. Current Medical Research and Opinion. 2023 May;39(5):661-669. doi: 10.1080/03007995.2023.2189857. PMID: 36897009
Impact of congestion and perfusion status in the emergency department on severity of decompensation and short-term prognosis in patients with acute heart failure. Espinosa B, Llorens P, Gil V, Jacob J, Alquezar-Arbe A, Masip J, Llauger L, Tost J, Andueza JA, Garrido JM, Soy-Ferrer E, Aguera-Urbano C, Herrero P, Gil-Rodrigo A, Millan J, Mecina AB, Torres-Garate R, Cabrera-Gonzalez N, Nunez J, Miro O. European Heart Journal. Acute Cardiovascular Care. 2023 Apr 3;12(3):165-174. doi: 10.1093/ehjacc/zuac115. PMID: 36137176
Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: the DAPA-MODA study. Pascual-Figal D, Zamorano J, Domingo M, Morillas H, Nunez J, Marcos M, Riquelme-PeTrez A, Teis A, Santas E, Caro-Martinez C, Pinilla J, Rodriguez-Palomares J, Dobarro D, Restrepo-Cordoba M, Gonzalez-Juanatey J, Genis A. European Journal of Heart Failure. 2023 Aug;25(8):1352-1360. doi: 10.1002/ejhf.2884. PMID: 37211950
Impact of persistent microvascular obstruction late after STEMI on AdverseLV remodeling: a CMR Study. Bodi V, Gavara J, Lopez-Lereu M, Monmeneu J, de Dios E, Perez-Sole N, Bonanad C, Marcos-Garces V, Canoves J, Minana G, Nunez J, Moratal D, Chorro F, Rodriguez-Palomares J, Freixa A, Borras R, Ortiz-Perez J, Rios-Navarro C. JACC. Cardiovascular Imaging. 2023 Jul;16(7):919-930. doi: 10.1016/j.jcmg.2023.01.021. PMID: 37052556
Impact of worsening renal function detected at emergency department arrival on acute heart failure short-term outcomes. Llauger L, Espinosa B, Rafique Z, Boone S, Beuhler G, Millan Soria J, Gil V, Jacob J, Alquezar Arbe A, Campos Meneses M, Escoda R, Tost J, Martin Mojarro E, Aguirre A, Lopez Grima ML, Nunez J, Mullens W, Lopez Ayala P, Mueller C, Llorens P, Peacock F, Miro O. European Journal of Emergency Medicine. 2023 Apr 1;30(2):91-101. doi: 10.1097/MEJ.0000000000001016. PMID: 36787242
Implications of worsening renal function before hospitalization for acute heart failure. Wettersten N, Duff S, Horiuchi Y, van Veldhuisen D, Mueller C, Filippatos G, Nowak R, Hogan C, Kontos M, Cannon C, Mueller G, Birkhahn R, Taub P, Vilke G, McDonald K, Mahon N, Nunez J, Briguori C, Passino C, Maisel A, Murray P, Ix J. ESC Heart Failure. 2023 Feb;10(1):532-541. doi: 10.1002/ehf2.14221. PMID: 36325747
Improvement in left atrial strain following ferric carboxymaltose in heart failure: an analysis of the Myocardial-IRON trial. Santas E, Del Canto I, Cardells I, Miñana G, Llácer P, Almenar L, Fácila L, Maceira A, Sanchis J, Núñez J. ESC Heart Failure. 2023 Dec 20. doi: 10.1002/ehf2.14630. PMID: 38115745
Intrarenal venous flow pattern changes do relate with renal function alterations in acute heartfailure. De la Espriella R, Nunez-Marin G, Cobo M, de Castro Campos D, Llacer P, Manzano L, Zegri I, Rodriguez-Perez A, Santas E, Lorenzo M, Minana G, Nunez E, Gorriz J, Bayes-Genis A, Fudim M, Mullens W, Nunez J. JACC. Heart Failure. 2023 Aug 22:S2213-1779(23)00411-0. doi: 10.1016/j.jchf.2023.07.015. PMID: 37676214
Is dapagliflozin a cardiac anti-aging drug?. Bayes-Genis A, Nunez J. JACC. Heart Failure. 2023 Mar;11(3):305-306. doi: 10.1016/j.jchf.2022.10.008. PMID: 36647928
Kidney function changes in acute heart failure: a practical approach to interpretation and management. Kenneally L, Lorenzo M, Romero-Gonzalez G, Cobo M, Nunez G, Gorriz J, Barrios A, Fudim M, de la Espriella R, Nunez J. Clinical Kidney Journal. 2023 Feb 20;16(10):1587-1599. doi: 10.1093/ckj/sfad031. PMID: 37779845
Lipoprotein(a) and long-term recurrent infarction after an acute myocardial infarction. Miñana G, Cordero A, Fácila L, Company M, Fernández-Cisnal A, Valero E, Carratalá A, Navarro J, Llergo J, Fernández-Olmo R, Castro A, Bodi V, Sanchis J, Núñez J. American Journal of Cardiology. 2023 Oct 18:211:9-16. doi: 10.1016/j.amjcard.2023.10.028. PMID: 37858663
Long-term recurrent events in ST-elevation myocardial infarction and multivessel disease. The impact of different revascularization strategies. Rumiz E, Vilar JV, Cubillos A, Valero E, Berenguer A, Facila L, Vidal V, Fernandez C, Llopis G, Paya R, Nunez J. Revista Portuguesa de Cardiologia. 2023 May;42(5):445-451. doi: 10.1016/j.repc.2023.01.021. PMID: 36706913
Maximal functional capacity in subjects with isolated left bundle branch block: a pilot study. Palau P, Mendez J, Santas E, Nunez J, Lopez L, Briatore A, Dominguez E. Clinical Cardiology. 2023 Apr;46(4):386-389. doi: 10.1002/clc.23977. PMID: 36756685
MRI investigation of the differential impact of left ventricular ejection fraction after myocardial infarction in elderly vs. nonelderly patients to predict readmission for heart failure. Marcos Garces V, Merenciano Gonzalez H, Gavara J, Gabaldon Perez A, Lopez Lereu MP, Monmeneu JV, Nunez J, Perez N, Rios Navarro C, de Dios E, Chorro FJ, Valente F, Lorenzatti D, Domenech Ximenos B, Alonso Tello A, Maymi Ballesteros M, Rello Sabate P, Morr CI, Ortiz Perez JT, Rodriguez Palomares JF, Bodi V. Journal of Magnetic Resonance Imaging. 2023 Nov;58(5):1507-1518. doi: 10.1002/jmri.28632. PMID: 36748793
Noncardiovascular morbidity and mortality across left ventricular ejection fraction catefories following hospitalization for heart failure. Santas E, Llacer P, Palau P, de la Espriella R, Minana G, Lorenzo M, Marin G, Miro O, Chorro F, Genis A, Sanchis J, Nunez J. Revista Espanola de Cardiologia (English ed.). 2023 Jun 12;S1885-5857(23)00158-5. doi: 10.1016/j.rec.2023.05.005. PMID: 37315921
Optimizing the management of patients with worsening heart failure: beyond heart failure hospitalization. Esteban Fernandez A, Recio Mayoral A, Gonzalez Franco A, Nunez Villota J, Mirabet S, Rubio Gracia J, Gonzalez Costello J, Bonilla Palomas J, Escobar Cervantes C. Expert Opinion on Pharmacotherapy. 2023 Apr;24(6):705-713. doi: 10.1080/14656566.2023.2195540. PMID: 36961877
Overlapping versus single long stents in long chronic total occlusions: insights of the Iberian CTO Registry. Jurado-Roman A, Minana G, Salinas P, Regueiro A, Caballero-Borrego J, Martin-Moreiras J, Rivero F, Lacunza J, Rondan J, Amat-Santos I, Sanchis J, Gonzalo N, Sabate M, Astorga J, Mohandes M, Gomez-Menchero A, Fernandez Diaz J, Ojeda S, Paredes E, Vaquerizo B, Vinhas H, Lopez M, Rodriguez S, Rumiz E, Jimenez-Mazuecos J, Lee D, Robles J, Gutierrez A, Morales F, Consuegra L, Maristany J, Bosa Ojeda F, Goicolea J, Escaned J, Galeote G. Minerva Cardiology and Angiology. 2023 Jun;71(3):284-293. doi: 10.23736/S2724-5683.22.06046-X. PMID: 35420282
Performance of an artificial intelligence chatbot with web search capability in cardiology-related assistance: a simulation study. Fernandez-Cisnal A, Lopez-Ayala P, Minana G, Boeddinghaus J, Mueller C, Sanchis J. Revista Espanola de Cardiologia (English ed.). 2023 Dec;76(12):1065-1067. doi: 10.1016/j.rec.2023.06.008. PMID: 37506970
Peritoneal and urinary sodium removal in refractory congestive heart failure patients included in an ambulatory peritoneal dialysis program: valuable for monitoring the course of the disease. Minana G, Gonzalez-Rico M, de la Espriella R, Gonzalez-Sanchez D, Montomoli M, Nunez E, Fernandez-Cisnal A, Villar S, Gorriz J, Nunez J. Cardiorenal Medicine. 2023 Aug 16;13(1):211-220. doi: 10.1159/000531631. PMID: 37586337
Potential role of empagliflozin in myocardial iron repletion following ferric carboxymaltose for heart failure. Lorenzo M, Espriella R, Cardells I, Luis Gorriz J, Bayes-Genis A, Nunez J. Revista Espanola de Cardiologia (english Ed.). 2023 Feb;76(2):121-123. doi: 10.1016/j.rec.2022.06.003. PMID: 35662676
Prognostic significance of plasma chloride in elderly patients hospitalized for acute heart failure. Llacer P, Croset F, Nunez J, Campos J, Fernandez C, Fabregate M, Del Hoyo B, Ruiz R, Lopez G, Tello S, Lorenzo A, Fernandez J, Manzano L. ESC Heart Failure. 2023 Aug;10(4):2637-2647. doi: 10.1002/ehf2.14434. PMID: 37349910
QT interval and short-term outcome in acute heart failure. Miro O, Aguilo O, Trullas J, Gil V, Espinosa B, Jacob J, Herrero-Puente P, Tost J, Lopez-Grima M, Comas P, Bibiano C, Llauger L, Martin Mojarro E, Lopez-Diez M, Nunez J, Rafique Z, Keene K, Peacock F, Lopez-Ayala P, Mueller C, Montero Perez-Barquero M, Mont L, Llorens P. Clinical Research in Cardiology. 2023 Dec;112(12):1754-1765. doi: 10.1007/s00392-023-02173-9. PMID: 37004527
Risk of death associated with incident heart failure in patients with known or suspected chronic coronary síndrome. Nunez J, Lorenzo M, Minana G, Palau P, Monmeneu JV, Lopez-Lereu MP, Gavara J, Marcos-Garces V, Rios-Navarro C, Perez N, de Dios E, Nunez E, Sanchis J, Chorro FJ, Bayes-Genis A, Bodi V. ESC Heart Failure. 2023 Feb;10(1):264-273. doi: 10.1002/ehf2.14179. PMID: 36196583
Safety and feasibility of transradial access for percutaneous coronary intervention in chronic total occlusions. Diego-Nieto A, Nunez J, Minana G, Amat-Santos I, Salinas-Sanguino P, Mohande M, Regueiro A, Pan M, Lacunza J, Caballero-Borrego J, Antonio Fernandez-Diaz J, Cisnal A, Santos-Martinez S, Gonzalo N, Vaquerizo B, Rivero F, Jurado-Roman A, Abellan-Huerta J, Gonzalez E, Rondan-Murillo J, Benito M, Burgo J, Mazuecos J, Ojeda F, Moreno-Ambroj C, Sabate M, Ojeda S, Aguilar R, Perez M, Sanchis J, Campo-Prieto A, Escaned J, Goicolea J, Martin-Moreiras J. Revista Espanola de Cardiologia (english Ed.). 2023 Apr;76(4):253-260. doi: 10.1016/j.rec.2022.05.019. PMID: 35691552
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial. Borlaug B, Kitzman D, Davies M, Rasmussen S, Barros E, Butler J, Einfeldt M, Hovingh G, Moller D, Petrie M, Shah S, Verma S, Abhayaratna W, Ahmed F, Chopra V, Ezekowitz J, Fu M, Ito H, Lelonek M, Melenovsky V, Nunez J, Perna E, Schou M, Senni M, van der Meer P, Von Lewinski D, Wolf D, Kosiborod M. Nature Medicine. 2023 Sep;29(9):2358-2365. doi: 10.1038/s41591-023-02526-x. PMID: 37635157
Semaglutide in patients with heart failure with preserved ejection fraction and obesity. Kosiborod M, Abildstrom S, Borlaug B, Butler J, Rasmussen S, Davies M, Hovingh G, Kitzman D, Lindegaard M, Moller D, Shah S, Treppendahl M, Verma S, Abhayaratna W, Ahmed F, Chopra V, Ezekowitz J, Fu M, Ito H, Lelonek M, Melenovsky V, Merkely B, Nunez J, Perna E, Schou M, Senni M, Sharma K, Van der Meer P, von Lewinski D, Wolf D, Petrie M. New England Journal of Medicine. 2023 Sep 21;389(12):1069-1084. doi: 10.1056/NEJMoa2306963. PMID: 37622681
Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction. Butler J, Abildstrøm SZ, Borlaug BA, Davies MJ, Kitzman DW, Petrie MC, Shah SJ, Verma S, Abhayaratna WP, Chopra V, Ezekowitz JA, Fu M, Ito H, Lelonek M, Núñez J, Perna E, Schou M, Senni M, van der Meer P, von Lewinski D, Wolf D, Altschul RL, Rasmussen S, Kosiborod MN. Journal of the American College of Cardiology. 2023 Nov 28;82(22):2087-2096. doi: 10.1016/j.jacc.2023.09.811. PMID: 37993201
Short-course high-intensity statin treatment during admission for myocardial infarction and LDL-cholesterol reduction-impact on tailored lipid-lowering therapy at discharge. Marcos-Garces V, Merenciano-Gonzalez H, Martinez Mas M, Palau P, Climent Alberola J, Perez N, Lopez-Bueno L, Esteban Argente M, Valls Reig M, Munoz Alcover R, Pradillas Contreras I, Arizon Benito A, Paya Rubio A, Rios-Navarro C, de Dios E, Gavara J, Chorro F, Sanchis J, Bodi V. Journal of Clinical Medicine. 2023 Dec 25;13(1):127. doi: 10.3390/jcm13010127. PMID: 38202134
Short-term changes in hemoglobin and changes in functional status, quality of life, and natriuretic peptides after initiation of dapagliflozin in heart failure with reduced ejection fraction. Lorenzo M, Minana G, Palau P, Amiguet M, Seller J, Pinilla J, Dominguez E, Villar S, de la Espriella R, Nunez E, Gorriz J, Valle A, Bodi V, Sanchis J, Bayes-Genis A, Nunez J. Journal of Cardiac Failure. 2023 May;29(5):849-854. doi: 10.1016/j.cardfail.2023.02.008. PMID: 36871614
Short-term changes in klotho and FGF23 in heart failure with reduced ejection fraction-a substudy of the DAPA-VO2 study. Mora-Fernández C, Pérez A, Mollar A, Palau P, Amiguet M, de la Espriella R, Sanchis J, Górriz J, Soler M, Navarro-González J, Núñez J. Frontiers in Cardiovascular Medicine. 2023 Aug 25:10:1242108. doi: 10.3389/fcvm.2023.1242108. PMID: 37745119
Short-term changes in peak VO2 after initiation of dapagliflozin in heartfailure across iron status. Lorenzo M, Jacobs-Cachá C, Palau P, Amiguet M, Seller J, Núñez E, Espriella R, Górriz JL, Miñana G, Sanchis J, Bayés-Genis A, Soler MJ, Packer M, Núñez J; DAPA-VO2 Investigators. JACC. Heart Failure. 2023 Nov;11(11):1611-1622. doi: 10.1016/j.jchf.2023.07.010. PMID: 37676213
Should we banish morphine from the treatment of acute pulmonary oedema?. Lorenzo M, Nunez J. Emergencias. 2023 Feb;35(1):4-5. PMID: 36756910‘ target=’_blank’>36756910
Spot urinary sodium as a biomarker of diuretic response in acute heart failure. Oliva-Damaso N, Nunez J, Soler M. Journal of the American Heart Association. 2023 Sep 5;12(17):e030044. doi: 10.1161/JAHA.123.030044. PMID: 37609987
Sudden cardiac death in heart failure: a 20-year perspective from a mediterranean cohort. Codina P, Zamora E, Levy W, Cediel G, Santiago-Vacas E, Domingo M, Ruiz-Cueto M, Casquete D, Sarrias A, Borrellas A, Santesmases J, de la Espriella R, Nunez J, Aimo A, Lupon J, Bayes-Genis A. Journal of Cardiac Failure. 2022 Dec 12;S1071-9164(22)01222-2. doi: 10.1016/j.cardfail.2022.11.016. PMID: 36521725
The effect of an abdominopelvic exercise program alone VS in addition to postural instructions on pelvic floor muscle function in climacteric women with stress urinary incontinence. A randomized controlled trial. Fuentes-Aparicio L, Rejano-Campo M, Lopez-Bueno L, Donnelly G, Balasch-Bernat M. Physiotherapy Theory and Practice. 2023 Apr;39(4):738-749. doi: 10.1080/09593985.2022.2028323. PMID: 35068328
The influence of body mass index on clinical interpretation of established and novel biomarkers in acute heart failure. Horiuchi Y, Wettersten N, van Veldhuisen D, Mueller C, Nowak R, Hogan C, Kontos M, Cannon C, Birkhahn R, Vilke G, Mahon N, Nunez J, Briguori C, Duff S, Murray P, Maisel A. Journal of Cardiac Failure. 2023 Aug;29(8):1121-1131. doi: 10.1016/j.cardfail.2023.03.029. PMID: 37127240
Usefulness of urinary potassium to creatinine ratio to predict diuretic response in patients with acute heart failure and preserved ejection fraction. Llacer P, Nunez J, Croset F, Garcia M, Fabregate M, Ruiz R, Lopez G, Fernandez C, Del Hoyo B, Campos J, Gomis A, Manzano L. Clinical Cardiology. 2023 Aug;46(8):906-913. doi: 10.1002/clc.24040. PMID: 37287326
Valvular heart disease in patients on kidney replacement therapy: opening Pandora’s box. De la Espriella R, Romero-Gonzalez G, Nunez J. Clinical Kidney Journal. 2023 May 26;16(7):1045-1048. doi: 10.1093/ckj/sfad060. PMID: 37398695